TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 45 filers reported holding TARSUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,311,765 | +45.0% | 73,819 | +47.4% | 0.00% | – |
| Q2 2023 | $904,964 | +123.6% | 50,081 | +55.6% | 0.00% | – |
| Q1 2023 | $404,690 | +11.1% | 32,195 | +29.5% | 0.00% | – |
| Q4 2022 | $364,404 | -12.4% | 24,857 | +2.4% | 0.00% | – |
| Q3 2022 | $416,000 | -18.8% | 24,270 | -30.9% | 0.00% | – |
| Q2 2022 | $512,000 | +172.3% | 35,119 | +213.3% | 0.00% | – |
| Q1 2022 | $188,000 | -25.7% | 11,211 | -0.2% | 0.00% | – |
| Q4 2021 | $253,000 | -58.9% | 11,238 | -60.6% | 0.00% | – |
| Q3 2021 | $615,000 | +155.2% | 28,530 | +244.5% | 0.00% | – |
| Q2 2021 | $241,000 | -8.4% | 8,282 | +30.0% | 0.00% | – |
| Q4 2020 | $263,000 | – | 6,372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,084,370 | $30,432,000 | 4.62% |
| Vivo Capital, LLC | 2,312,368 | $33,761,000 | 3.39% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $26,098,000 | 2.46% |
| Cormorant Asset Management, LP | 1,875,000 | $27,375,000 | 2.07% |
| Sands Capital Ventures, LLC | 260,000 | $3,796,000 | 1.04% |
| Ghost Tree Capital, LLC | 120,000 | $1,752,000 | 0.91% |
| RTW INVESTMENTS, LP | 2,013,601 | $29,399,000 | 0.76% |
| COWEN AND COMPANY, LLC | 534,524 | $7,804,000 | 0.75% |
| Perceptive Advisors | 1,296,416 | $18,927,000 | 0.59% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,324,214 | $19,334,000 | 0.40% |